STOCK TITAN

Poseida Therapeutics, Inc. - PSTX STOCK NEWS

Welcome to our dedicated news page for Poseida Therapeutics (Ticker: PSTX), a resource for investors and traders seeking the latest updates and insights on Poseida Therapeutics .

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Poseida Therapeutics 's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Poseida Therapeutics 's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.21%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.08%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.16%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.17%
Tags
none
Poseida Therapeutics, Inc.

Nasdaq:PSTX

PSTX Rankings

PSTX Stock Data

223.85M
54.57M
34.52%
47.58%
4.27%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
SAN DIEGO

About PSTX

poseida therapeutics, inc. is currently developing car-t and gene therapy products for cancer and orphan diseases. spinout of transposagen biopharmaceuticals early this year, poseida is also collaborating with j&j’s janssen to develop allogeneic car-t therapies against cancer. poseida boasts best-in-class genome engineering capabilities for effectively silencing target genes or inserting therapeutic genes and/or technologies. proprietary tools include piggybac™ dna modification system, nextgen™ crispr, xtn™ talen and footprint-free™ gene editing system, which are clean (synthetic and virus-free) and can be surgically precise. poseida aims to shuttle the first car-t and gene therapy product candidates into phase i clinical trials in early 2016. poseida is now hiring and searching for ambitious and motivated scientists desiring a fast-paced work environment with diverse research opportunities in the field of cellular and gene therapy.